Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3501597013 | Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
3676787012 | Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Aspirin and carisoprodol and codeine only product in oral dose form | true | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Codeine phosphate | true | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has BoSS | Codeine phosphate | true | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has BoSS | Carisoprodol | true | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Carisoprodol | true | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Plays role | Antitussive therapeutic role | true | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Aspirin compound preparation | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Codeine phosphate product | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Codeine phosphate | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Morphinan opioid | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Aspirin | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Codeine | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Aspirin + carisoprodol + codeine phosphate | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Carisoprodol | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Aspirin-containing product in oral dose form | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Codeine-containing product in oral dose form | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has BoSS | Carisoprodol | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Carisoprodol | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has BoSS | Carisoprodol | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Codeine phosphate | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has BoSS | Codeine phosphate | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 16 | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has BoSS | Aspirin | true | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 325 | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Aspirin | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has BoSS | Aspirin | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 325 | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Codeine phosphate | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Carisoprodol | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Aspirin | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Carisoprodol | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Codeine phosphate | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Aspirin- and carisoprodol- and codeine-containing product in oral dose form | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Aspirin | true | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets